Welcome to the upgraded BRAC University Institutional Repository. We are currently organizing collections after a recent system upgrade. Homepage category counters may temporarily show lower numbers while syncing, but over 27,000 repository items remain safe and accessible. Please use the search bar to find theses, scholarly outputs, and institutional documents.

Finasteride-associated suicidality: a pharmacovigilance analysis of FAERS database

bracu.degree.levelUndergraduate
bracu.type.groupStudent Works
datacite.rightsOpen Access
dc.contributor.advisorTalukder, Mesbah
dc.contributor.authorKhan, Fardin Salekin
dc.contributor.departmentSchool of Pharmacy
dc.date.accessioned2026-06-07T07:26:12Z
dc.date.available2026-06-07T07:26:12Z
dc.date.copyright2022
dc.date.issued2022-11
dc.descriptionCataloged from PDF version of thesis.
dc.descriptionIncludes bibliographical references (pages 22-24).
dc.descriptionThis thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.en_US
dc.description.abstractThe adverse events of finasteride remained controversial since the introduction of the drug. However, after 2012, suicidality was reported to a greater extent. So, we investigated the association of suicidality and finasteride using FAERS database. We conducted a disproportionality analysis to identify signals of suicidality with finasteride using reporting odds ratio. Then, we obtained significant signals against whole database (ROR, 6.25; 95% CI, 5.85–6.67) and against drug of similar indication (minoxidil) (ROR, 55.1; 95% CI, 42.8–70.8). In sensitivity analyses, older patients showed significant signals for suicidal ideation (ROR, 16.5; 95% CI, 4.85-56.3) and for both before 2012 (ROR, 3.88; 95% CI, 1.04-14.41) and after 2012 (ROR, 4.04; 95% CI, 2.28-7.14). Hence, analyses confirmed that older patients have higher risk of suicidality compared to younger patients. Also, stimulated reporting did not cause suicidality to give signals for finasteride. However, there are certain limitations which needs further research attention.en_US
dc.description.degreeBachelor of Pharmacy
dc.description.statementofresponsibilityFardin Salekin Khan
dc.format.extent36 pages
dc.identifier.otherID 18346050
dc.identifier.urihttp://hdl.handle.net/10361/28311
dc.language.isoenen_US
dc.publisherBRAC Universityen_US
dc.rightsBRAC University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission.
dc.subjectSuicidalityen_US
dc.subjectFinasterideen_US
dc.subjectSuicidal ideationen_US
dc.subjectSuicide attempten_US
dc.subjectDrug monitoringen_US
dc.subjectDisproportionality analysisen_US
dc.subjectMental illnessen_US
dc.subject.lcshSuicidal behavior.
dc.subject.lcshFinasteride.
dc.subject.lcshSuicidal behavior--Risk factors.
dc.subject.lcshDrugs--Safety measures.
dc.subject.lcshDrug monitoring.
dc.subject.lcshPharmacovigilance.
dc.titleFinasteride-associated suicidality: a pharmacovigilance analysis of FAERS databaseen_US
dc.typeThesisen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
18346050_PHR.pdf
Size:
498.55 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: